Modular Medical, Inc.
MODDdata completeness 75%28 fiscal years on fileData notes: no data for concept 'totalDebt'
Modular Medical, Inc. earns about -550% on invested capital, and has bought back 66% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | −$18.6M1 | −$13.9M2 | −$17.5M3 | −$18.8M4 | −$28.2M4 |
| Operating cash flow | −$10.3M5 | −$11M6 | −$14M7 | −$15.7M8 | −$23.8M8 |
| Capital expenditure | $54,7649 | $1.64M10 | $1.7M11 | $2.49M12 | $3.93M12 |
| Free cash flow (derived) | −$10.3M5 | −$12.6M6 | −$15.7M7 | −$18.2M8 | −$27.7M8 |
| Total debt | — | — | — | — | — |
| Cash & equivalents | $9.08M13 | $3.8M14 | $9.23M15 | $13.1M16 | $6.94M16 |
| Diluted shares | 6.8M | 12.1M | 22.4M | 1.2M | 2.3M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $56.71 of net worth that earned you −$123.6 and generated −$121.16 of cash last year.
It earned an average -550% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 66% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2022-03-31 · accession 0001213900-23-051688 (NetIncomeLoss)
- 10-K · period ending 2023-03-31 · accession 0001213900-24-054877 (NetIncomeLoss)
- 10-K · period ending 2024-03-31 · accession 0001213900-25-055793 (NetIncomeLoss)
- 10-K · period ending 2025-03-31 · accession 0001213900-26-073223 (NetIncomeLoss)
- 10-K · period ending 2022-03-31 · accession 0001213900-23-051688 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-03-31 · accession 0001213900-24-054877 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-03-31 · accession 0001213900-25-055793 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2025-03-31 · accession 0001213900-26-073223 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-03-31 · accession 0001213900-23-051688 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-03-31 · accession 0001213900-24-054877 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-03-31 · accession 0001213900-25-055793 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2025-03-31 · accession 0001213900-26-073223 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-03-31 · accession 0001213900-23-051688 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-03-31 · accession 0001213900-24-054877 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-03-31 · accession 0001213900-25-055793 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2025-03-31 · accession 0001213900-26-073223 (CashAndCashEquivalentsAtCarryingValue)